Why Moderna is still the ultimate stock hedge against any outbreak

Will a hantavirus outbreak offset the regulatory risks weighing on Moderna stock? The path to recovery is far from certain.
RAPS

Asia-Pacific Roundup: TGA makes Moderna’s Spikevax the first fully registered COVID vaccine

Australia’s Therapeutic Goods Administration (TGA) has upgraded Moderna’s COVID-19 vaccine to full registration, making Spikevax the first COVID-19 vaccine to transition from provisional to full ...

CureVac sues Moderna for patent infringement over COVID-19 vaccines

By Blake Brittain April 24 (Reuters) - German biotech company CureVac sued Moderna in Delaware federal court on Friday, alleging that Moderna's COVID-19 vaccine Spikevax infringed CureVac patents ...

Moderna’s Spikevax COVID-19 vaccine evaluated by TGA for babies and toddlers

Australia’s medicines regulator has confirmed it is evaluating a low dose for children as young as six-months-old.
Medscape

EU Panel Clears Path for Updated Moderna COVID Vaccine

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use has recommended granting marketing authorization for Moderna’s new RNA-based vaccine, mNexspike, for preventing ...
Miami Herald

Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKE

mNEXSPIKE is the third Moderna vaccine authorized in the European Union, strengthening the Company's respiratory vaccine portfolio in Europe CAMBRIDGE, MA / ACCESS Newswire / February 17, 2026 / ...
USA Today

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s mNEXSPIKE (COVID-19 Vaccine, mRNA)

CAMBRIDGE, MA / ACCESS Newswire / December 15, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has ...